B-Cell Lymphomas Panel - Disclosures
|
Panel Member
|
Jeremy Abramson MD, MMSc |
|
Grant/Research Support
|
| Bristol Myers Squibb | Celgene Corporation | Genentech, Inc. | Merck & Co., Inc. | Mustang Bio | Regeneron Pharmactcls | SeaGen | Takeda Pharmaceuticals North America, Inc. |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Ranjana Advani MD |
|
Grant/Research Support
|
| BeiGene | Daiichi- Sankyo Co. | Genentech, Inc. | Merck & Co., Inc. | Millennium Pharmaceuticals, Inc. | Regeneron Pharmactcls | Roche Laboratories, Inc. | SeaGen |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Babis Andreadis MD, MSCE |
|
Grant/Research Support
|
| Bristol Myers Squibb | Eli Lilly and Company | Genmab | Novartis Pharmaceuticals Corporation | Roche Laboratories, Inc. |
|
Date Completed
|
03/17/2025 |
|
Panel Member
|
Nancy Bartlett MD |
|
Grant/Research Support
|
| ADC Therapeutics | Autolus | BMS/Celgene | Forty Seven/Gilead | Genmab | Gilead/Kite Pharma | Janssen Pharmaceutica Products, LP | Millennium Pharmaceuticals, Inc. | Pharmacyclics | Roche/Genentech | SeaGen |
|
Date Completed
|
06/24/2024 |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Elizabeth Lihua Budde MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Paolo Caimi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Julie Chang MD |
|
Grant/Research Support
|
| Celgene Corporation | Genentech, Inc. |
|
Date Completed
|
06/18/2024 |
|
Panel Member
|
Sven DeVos MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bhagirathbhai Dholaria MD |
|
Grant/Research Support
|
| Adicet | allovir | Angiocrine | Atara | Gilead Sciences, Inc. | Janssen Pharmaceutica Products, LP | MEI | Orca Bio | Pfizer Inc. | POSEIDA | Takeda Pharmaceuticals North America, Inc. | wugen |
|
Date Completed
|
08/19/2024 |
|
Panel Member
|
Mary Dwyer MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Meghan Fay BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Luis Fayad MD |
|
Grant/Research Support
|
| Roche Laboratories, Inc. |
|
Date Completed
|
03/05/2025 |
|
Panel Member
|
Tanya Fischer MEd, MLIS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Leo Gordon MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Thomas Habermann MD |
|
Grant/Research Support
|
| Genentech, Inc. | Sorrento |
|
Date Completed
|
08/21/2024 |
|
Panel Member
|
Muhammad Saad Hamid MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Laura Hanisch PsyD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Francisco Hernandez-Ilizaliturri MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Boyu Hu MD |
|
Grant/Research Support
|
| Artiva Biotherapeutics | AstraZeneca Pharmaceuticals LP | Caribous Biosciences | Celgene Corporation | CRISPR Therapeutics | Genentech, Inc. | ImmPACT Bio | MorphoSys AG | Newave | Repare Therapeutics |
|
Date Completed
|
07/15/2024 |
|
Panel Member
|
Yasmin Karimi MD |
|
Grant/Research Support
|
| AbbVie, Inc. | AstraZeneca Pharmaceuticals LP | BeiGene | Eli Lilly and Company | Genentech, Inc. | Gilead Sciences, Inc. | Merck & Co., Inc. | Pfizer Inc. | Xencor |
|
Product/Speakers Bureau
|
| AbbVie, Inc. |
|
Date Completed
|
06/19/2024 |
|
Panel Member
|
Ann Karosas RPh, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christopher Kelsey MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rebecca King MD |
|
Royalty Income
|
| Wolters Kluver publishing |
|
Date Completed
|
08/27/2024 |
|
Panel Member
|
Justin Kline MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Susan Krivacic MPAff |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ann LaCasce MD, MMSc |
|
Product/Speakers Bureau
|
| Research to Practice |
|
Date Completed
|
03/14/2025 |
|
Panel Member
|
Daniel Landsburg MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Megan Lim MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Megan Lyons MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marcus Messmer MD |
|
Grant/Research Support
|
| BeiGene |
|
Date Completed
|
07/11/2024 |
|
Panel Member
|
Kristen Morris BSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
John Murphy |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rachel Rabinovitch MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Praveen Ramakrishnan MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Reid MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kenneth Roberts MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aditi Saha MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Naoyuki Saito MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Yazeed Sawalha MD |
|
Grant/Research Support
|
| AbbVie, Inc. | BeiGene | Genmab |
|
Date Completed
|
05/13/2025 |
|
Panel Member
|
Stephen Smith MD |
|
Grant/Research Support
|
| ADC Therapeutics | AstraZeneca Pharmaceuticals LP | Bayer HealthCare | BeiGene | DeNovo Biopharma | Enterome | Genentech, Inc. | Incyte Corporation | Kymera Therapeutics | Merck & Co., Inc. | MorphoSys AG | Nanjing pharmaceuticals | Viracta Therapeutics |
|
Date Completed
|
03/13/2025 |
|
Panel Member
|
Hema Sundar PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lode Swinnen MBChB |
|
Grant/Research Support
|
| AbbVie, Inc. |
|
Date Completed
|
07/19/2024 |
|
Panel Member
|
Joseph Tuscano MD |
|
Grant/Research Support
|
| Genentech, Inc. | Pfizer Inc. | Pharmacyclics |
|
Date Completed
|
08/28/2024 |
|
Panel Member
|
Julie Vose MD, MBA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Andrew Zelenetz MD, PhD |
|
Grant/Research Support
|
| BeiGene | Genentech, Inc. | MEI Pharma Inc. | Roche Laboratories, Inc. |
|
Date Completed
|
06/28/2024 |
